Literature DB >> 21784141

European Paediatric Formulation Initiative's (EuPFI) 2nd conference commentary--Formulating better medicines for children.

Smita Salunke1, John Hempenstall, Richard Kendall, Bénédicte Roger, Carl Mroz, Tony Nunn, Catherine Tuleu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21784141     DOI： 10.1016/j.ijpharm.2011.06.040

Source DB:  PubMed          Journal:  Int J Pharm        ISSN： 0378-5173            Impact factor:   5.875


× No keyword cloud information.
  4 in total

1.  Retapamulin prescriptions and monitored off-label use.

Authors:  Linda M Mundy; Tim Sampson; John W Logie
Journal:  Paediatr Drugs       Date:  2014-08       Impact factor: 3.022

2.  Solid oral forms availability in children: a cost saving investigation.

Authors:  Audrey Lajoinie; Emilie Henin; Behrouz Kassai; David Terry
Journal:  Br J Clin Pharmacol       Date:  2014-11       Impact factor: 4.335

3.  Dosage form preference consultation study in children and young adults: paving the way for patient-centred and patient-informed dosage form development.

Authors:  Hamad Alyami; Eman Dahmash; Fahad Alyami; Dania Dahmash; Chi Huynh; David Terry; Afzal R Mohammed
Journal:  Eur J Hosp Pharm       Date:  2016-09-02

4.  Children's Preferences for Oral Dosage Forms and Their Involvement in Formulation Research via EPTRI (European Paediatric Translational Research Infrastructure).

Authors:  Elisa Alessandrini; Francis Brako; Mariagiovanna Scarpa; Mariangela Lupo; Donato Bonifazi; Valeria Pignataro; Maria Cavallo; Ornela Cullufe; Cristina Enache; Begonya Nafria; Joana Claverol; Leen De Taeye; Eric Vermeulen; Jennifer Preston; Catherine Tuleu
Journal:  Pharmaceutics       Date:  2021-05-15       Impact factor: 6.321
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.